Back
Range Cancer Therapeutics ETF Stock Price Chart
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13
CNCR
Range Cancer Therapeutics ETF
Last Price:
$8.74
Seasonality Move:
1.66%
7 Day Trial
ALL ACCESS PASS
$
7
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Range Cancer Therapeutics ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.66 | Sell |
| 20-day SMA: | 9.71 | Sell |
| 50-day SMA: | 11 | Sell |
| 200-day SMA: | 13.39 | Sell |
| 8-day EMA: | 8.55 | Sell |
| 20-day EMA: | 7.25 | Buy |
| 50-day EMA: | 4.4 | Buy |
| 200-day EMA: | 1.39 | Buy |
Range Cancer Therapeutics ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.78 | Buy |
| Relative Strength Index (14 RSI): | 31.66 | Sell |
| Chaikin Money Flow: | 1911 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.97 - 10.93) | Sell |
| Bollinger Bands (100): | (10.48 - 13.6) | Sell |
Range Cancer Therapeutics ETF Technical Analysis
| Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Range Cancer Therapeutics ETF Stock
Is Range Cancer Therapeutics ETF Stock a Buy?
-
Range Cancer Therapeutics ETF share price is 8.40 while CNCR 8-day simple moving average is 8.66, which is a Sell signal.
-
The stock price of CNCR is 8.40 while Range Cancer Therapeutics ETF 20-day SMA is 9.71, which makes it a Sell.
-
Range Cancer Therapeutics ETF 50-day simple moving average is 11.00 while CNCR share price is 8.40, making it a Sell technically.
-
CNCR stock price is 8.40 and Range Cancer Therapeutics ETF 200-day simple moving average is 13.39, creating a Sell signal.
CNCR Technical Analysis vs Fundamental Analysis
Sell
13
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy or a Sell?
-
Range Cancer Therapeutics ETF stock is rated a SellThe current Range Cancer Therapeutics ETF [CNCR] share price is $8.40. The Score for CNCR is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Range Cancer Therapeutics ETF Stock Info
Market Cap:
0
Price in USD:
8.40
Share Volume:
1.9K
Range Cancer Therapeutics ETF 52-Week Range
52-Week High:
16.27
52-Week Low:
7.88
Sell
13
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Range Cancer Therapeutics ETF Share Price Forecast
-
What is the Range Cancer Therapeutics ETF stock price today?The Range Cancer Therapeutics ETF stock price is 8.40 USD today.
-
Will CNCR stock go up or go down?Range Cancer Therapeutics ETF> share price is forecast to RISE/FALL based on technical indicators
-
Is Range Cancer Therapeutics ETF overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Range Cancer Therapeutics ETF is overvalued.
Is Range Cancer Therapeutics ETF Stock a Buy?
-
Range Cancer Therapeutics ETF share price is 8.40 while CNCR 8-day exponential moving average is 8.55, which is a Sell signal.
-
The stock price of CNCR is 8.40 while Range Cancer Therapeutics ETF 20-day EMA is 7.25, which makes it a Buy.
-
Range Cancer Therapeutics ETF 50-day exponential moving average is 4.40 while CNCR share price is 8.40, making it a Buy technically.
-
CNCR stock price is 8.40 and Range Cancer Therapeutics ETF 200-day simple moving average is 1.39, creating a Buy signal.
Technical Analysis of Range Cancer Therapeutics ETF
Should I short Range Cancer Therapeutics ETF stock?
-
CNCR Moving Average Covergence Divergence (MACD) indicator is 1.78, suggesting Range Cancer Therapeutics ETF is a Buy
-
Range Cancer Therapeutics ETF Relative Strength Index (RSI) is 31.66, which suggest Range Cancer Therapeutics ETF is oversold
-
The Bollinger Bands (25) for Range Cancer Therapeutics ETF is (8.97 - 10.93), which suggest Range Cancer Therapeutics ETF is a Sell
-
The Bollinger Bands (100) for Range Cancer Therapeutics ETF is (10.48 - 13.6), which suggest Range Cancer Therapeutics ETF is a Sell
* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.